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Mice homozygous for recessive mutations at the "motheaten" locus on chro-
mosome 6 (1) are an important experimental model for studying the origin,
immunochemistry, and molecular properties of autoantibodies . Two such allelic
mutations have arisen spontaneously in the C57BL/6J strain : the original moth-
eaten (me) (2), and the later viable motheaten (me") (3) mutations, whose homo-
zygotes live to average ages of 3 and 9 wk, respectively . Both types of mice
develop a rapidly fatal disease characterized by hyperglobulinemia, production
of a variety of autoantibodies (including antithymocyte and anti-red blood cell),
and a number of lesions suggestive of an autoimmune pathology: neutrophilic
dermatitis, thymic atrophy, glomerular immune complexes, interstitial hemor-
rhagic pneumonitis (which is usually the immediate cause of death), and swollen
limb joints (1) .
The B cells of viable motheaten mice have been shown to be all or nearly all
of the Ly-1 + phenotype (Ly-1 B cells) (4) . Ly-1 B cells are thought to represent
a distinct lineage ofB cells possessing an immature phenotype (5) and containing
many or most of the precursors of autoantibody forming cells (6).
Because of the severity of the autoimmune syndrome in these mice, including
the elaboration of autoantibodies exhibiting a variety of specificities, we exam-
ined and here report the immunochemical specificities and V gene family usage
of mAb secreted from hybridomas obtained from viable motheaten mice . The
results obtained show that the autoantibodies expressed in these mice exhibit a
wide range of single and multiple reactivities to self antigens and are not derived
from a restricted set of V gene families .
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Materials and Methods
Mice
1-2-mo-old viable motheaten (C57BL/6JSmn-me"/me") and control (C57BL/6JSmn)
mice were used .
Hybridomas
Hybridomas were obtained from 1- or 2-mo-old viable motheaten mice by fusion of
splenocytes with the Sp2/0 cell line in accordance with a previously described technique
This investigation was supported by U.S . Public Health Service grants AI-18361, CA-35845, and
AI-20232 ; and by grant 2092 from the Council for Tobacco Research, USA, Inc .
J . ExP. MED. © The Rockefeller University Press - 0022-1007/88/03/1137/17 $2.00
￿
11371138
￿
VIABLE MOTHEATEN ANTIBODIES
(7). Hybridomas secreting autoantibodies were cloned under stringent limiting dilution
conditions (0.5 cell/well).
Antigen Specificity ofMonoclonal Antibodies
Antigens.
￿
A panel of autoantigens were used to determine the specificity ofme" mAbs.
These antigens are generally thought to be involved in autoimmune diseases. Intrinsic
factor (IF)' was purchased from ICN Biochemical Inc. (Irvine, CA); thyroglobulin (TG)
and cardiolipin from Sigma Chemical Co. (St. Louis, MO), and murine transferrin (TR)
from U.S. Biochemical Corp. (Cleveland, OH). Immunoglobulins of the y3, -11, -y2b, or
y2a isotypes (each bearing a light chains) were purified from culture supernatants of the
J606 myeloma, or the 88-C692, BA6, or HOPC 1 hybridomas, respectively. Acetylcholine
receptor (AcR) was a gift from Dr. A. Penn (Columbia University, New York, NY); Sm,
extracted from MRL/lpr thymocytes, was a gift from Dr. H. Dang (University of South
Texas, San Antonio, TX); and myelin basic protein (MBP) from seven different species
was from Dr. Hashim (St. Luke's Roosevelt Hospital, New York).
Radioimmunoassay.
￿
RIA was used to detect antibodies reacting with bromelain-treated
RBC membrane, guinea pig MBP, murine TR, murine aggregated IgG, porcine TG,
murine Sm, torpedo AcR, murine type II or type III collagen (CII or CIII), IF, cardiolipin,
and thymocytes (Thy). Microtiter plate wells were coated with 50,ul of 10 ,ug/ml of soluble
autoantigen in carbonate buffer, pH 9.0, except that Sm was used at 1 ,ug/ml, MBP at 20
ttg/ml, and cardiolipin (in 95% ethanol) at 50,ug/ml. After overnight incubation at 4°C,
the plates were incubated for 1 h at 4° C with 1 % BSA-PBS and then washed three times.
50,ul of hybridoma cell culture supernatant or chromatographically purified antibody (10
Ag/ml) was added per well for 3 h at room temperature; plates were then washed and
incubated for 2 h with 1251-rat anti-murine K mAb (50,000 cpm/well); all hybridomas
producing autoantibodies had been previously shown to use K lightchains. After extensive
washings, the radioactivity remaining in the wells was counted in a Biogamma TM
radiation counter (Beckman Instruments, Inc., Fullerton, CA). Specificity was further
studied by competitive inhibition RIA. In these studies, 50 jul (at 10 ,ug/ml) of a given
mAb was preincubated for 2 h at room temperature with 50 jul of 10 or 30 jug/ml
autoantigen and then transferred to microtiter plates coated with the antigen as previously
noted. The binding was determined by RIA, as above. Antithymocyte antibodies were
detected by RIA as above, using 100,000 thymocytes per well.
Immunoperoxidase Assay.
￿
Immunoperoxidase staining was used to detect binding activ-
ity against human skin and murine lung cryostat sections. Cryostat sections were incubated
for 1 h at 4°C with 0.5 ml of 10 jug/ml chromatographically purified antibody, washed
several times, and then incubated for 1 h with horseradish peroxidase-conjugated rabbit
anti-mouse Ig antibodies.
Immunofluorescence. Rat stomach and kidney frozen sections were used to detect
antinuclear, antimitochondrial, anti-smooth muscle, and anti-glomerular basal membrane
antibodies according to a previously described technique (8). Antithymocyte and anti-
RBC antibodies were detected by incubating 106 cells (from control C57BL/6J mice) for
45 min on ice with 50 pl of 1 :2 diluted culture supernatant, washing three times, and
then incubating for 45 min on ice with 20 ul of 1 :10 diluted fluoresceinated goat anti-
mouse Ig (Southern Biotechnology Associates, Inc., Birmingham, AL). After three washes,
the fluorescence was measured using a cytofluorograph (model 50H; Ortho Diagnostic
Systems Inc., Westwood, MA).
V Gene Probes.
￿
Plasmids of interest were transfected into Escherichia coli HB101 :
HB101 were grown to a A Klett of 40-60, pelleted, and resuspended in 0.5X volume of
50 mM cold CaC12 and incubated on ice for 40 min; bacteria were repelleted and
resuspended in 0.2X volume of 50 mM cold CaC12 and incubated on ice for 10 min. 5-
10 ng of plasmid were mixed with 0.2 ml of bacteria and incubated 15 min on ice, then
2 min at 37'C, and finally 10 min at room temperature. After addition of nonselective
`Abbreviations used in this paper:
￿
AcR, acetyl choline receptor; CII or CIII, murine collagen type
11 or 111; IF, intrinsic factor; MBP, myelin basic protein; RF, rheumatoid factor; TG, thyroglobulin;
TR, transferrin.PAINTER ET AL.
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LB medium and incubation for 1 h at 37°C, the transformation mixture was plated with
100 kg/ml ampicillin. Single colonies were expanded in bulk cultures and plasmids were
prepared by the alkali lysis method (9), except that 3 M sodium acetate brought to pH
4.8 with glacial acetic acid was used. After CsCl density gradient centrifugation (9),
purified plasmids were digested with appropriate restriction enzymes (New England
Biolabs, Beverly, MA, or IBI), after which probes were isolated by electroelution (200 V,
30 min; 30-s reverse current) in 0.5x TBE (9) from slices from 5% polyacrylamide gels
(9).
Purified probes (100 ng) were nick translated with 60 ACi of a-[s2P]dCTP (3,000
Ci/mol, Amersham Corp., Arlington Heights, IL) to a sp act of ?1 x 106 cpm/Ag. The
reaction contained 2 ul each of 10-25 nM dATP, dTTP, and dGTP (Pharmacia Fine
Chemicals, Piscataway, NJ), 1 jA1 of 0.1 ng/ml DNAse I (Worthington Biochemical Corp.,
Freehold, NJ), and 5 U Kornberg DNA polymerase I (New England Biolabs) in 1 x nick
translation buffer (50 mM Tris-HCl pH 7.8, 5 MM MgCl2, 10 MM 2-ME, 50 jAg/ml BSA).
Incubation was at 14-16°C for 75 min, after which 2 pl of 0.5 M EDTA and 10 Isg of
tRNA (Sigma Chemical Co.) were added. Probe was separated from unincorporated label
using a G-50 Sephadex spin column in a 3-ml syringe packed in H2O and prerun with 1
ml of TE, pH 7 .4, containing 100 wg of salmon sperm DNA (Sigma Chemical Co.) (9).
The following five VH gene probe constructs (prepared in the laboratory of F. Alt,
Columbia University) are in SP65 plasmids: the VH J606 probe is a Hind III/Eco RI
fragment containing the 300-bp Hind III/Bgl II fragment of a rearranged A/J anti-GAC
VH gene (10); the VH 36-60 probe is a 350-bp Eco RI/Pvu II fragment containing the
140-bp Bam HI/Eco RI fragment of the VH 36-60 gene (11); the VH NP.B4 probe (VH
family J558) is a 315-bp Pst I/Eco RI BALE/c germline VH gene fragment (12); the VH
S107 probe is a 213-bp Dde I fragment, isolated from a rearrangement, which was
subcloned after addition of Eco RI linkers (13); and the VH QPC52 probe is a 300-bp Pvu
II/Hae III fragment subcloned after addition of Eco RI linkers (14). The VH81X probe
(VH family 7183) (kindly given by G. Yancopoulos and F. Alt, Columbia University) is a
280-bp Pst I/Eco RI fragment containing the Pvu II/Pst I fragment of the germline
VH81X(G) gene cloned in SP64 (15). The VH 441-4 probe (VH X24 family) (graciously
given by A. B. Hartmann and S. Rudikoff, National Cancer Institute, NIH, Bethesda,
MD) is a 500-bp Eco RI fragment of a germline gene cloned into pUC8 (clone Gal 39.1)
(16). The VH 36-09 probe (kindly provided by D.J. Capra, Texas Medical Center, Dallas,
TX) is a 1 .6-kb Eco RI/Bam HI fragment in pUC12 (17).
The VK 1 probe (generously given by C. Schiff and M. Fougereau, Centre d'Immunol-
ogie, INSERM, CNRS, Marseille, France) is a 300-bp Dde I fragment from the LXIX27
cDNA cloned into pBR322 (18). The V,4 probe (generously supplied by M . Heller and
S. Rudikoff, NCI) is a 260-bp Pvu II/Ava I fragment of a pBR322 clone containing a
400-bp cDNA. The Vr8 probe (kindly provided by P. Gearhart, Baltimore, MD) is a 360-
bp cDNA fragment cloned into the Sma I site of pUC9 (18a). The VK10 probe (clone
pC3386, obtained through the generosity of M. Shapiro and M. Weigert, Institute for
Cancer Research, Philadelphia, PA) is a 900-bp Eco RI/Hind III fragment of a nonpro-
ductive K gene rearrangement cloned into pUC12 (19). The V.19 probe is a 400-bp Eco
RI/Hind III fragment from a pBR322 plasmid into the Pst I site of which the Pvu II/Hpa
II fragment ofthe MPC 11 V, gene cDNA was subcloned (20). The VK21 probe (generously
provided, along with the VK19 probe, by D. Kelly and R. Perry, Institute for Cancer
Research) is a 700-bp Hind III/Hha I fragment from a pBR322 plasmid containing cDNA
sequence of MOPC321 (21). The VK22 probe (a gift from P. Gearhart) is a 1 .2-kb Xba
fragment of the VRS107A rearranged genomic clone in pBR322 (21a). The VK24 probe
(kindly given by P. Gearhart) is a 900-bp Hind III germline gene fragment from BALB/c
mice cloned into the Hind III site of pBR322 (22). The VK2 probe is a 350-bp Pst I/Mbo
II fragment of a pBR322 clone of the M603K2 1-kb cDNA (23). The V,9 probe (kindly
supplied along with the VR2 probe F. Alt, Columbia University) is a 350-bp Pst I/Mbo II
fragment of a pUC9 clone of the M41K1 950-bp cDNA (23).1140
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TABLE I
Frequency ofIg SecretoryHybridomas Obtainedfrom Motheaten Mice
* 14/41 Ig secretors were lost before they could be analyzed.
Preparation of Total RNA and Northern Blot Analysis
Total RNA was prepared from 3-5 X 10' cells using the guanidinium thiocyanate
extraction procedure (9). Northern blotting was performed by electrophoretically frac-
tionating the RNA on a 1.2% agarose gel (6% formaldehyde) in 40 mM 4-morpholino-
propanesulfonic acid, 20 mM NaOAc, and 2 mM EDTA. The gel was blotted overnight
(without pretreatment) onto nitrocellulose using 20X SSC (3 M NaCl, 0.3 M sodium
citrate) (8). Blots were baked in a vacuum oven 2 h at 80°C.
Prehybridization was carried out at 42°C in 50% formamide, 5X SSCPE (20X = 2.4
M NaCl, 0.3 M sodium citrate, 0.2 M KH2PO4, 0.02 M EDTA), 5X Denhardt's, 500
,ug/ml sheared denatured salmon sperm DNA. Probe was added to 106 cpm/ml in
hybridization solution (50% formamide, 5X SSCPE, IX Denhardt's, 100 kg/ml salmon
sperm DNA, and 10% dextran sulfate). Blots were hybridized overnight at 42 °C. Blots
were washed three times for 15 min in 2X SSC, 0.1 % SDS at 68°C and exposed to Kodak
XAR film using Dupont Lightning Plus intensifying screens at -70°C for several days.
V blots were rewashed in 0.1X SSC, 0.1% SDS at 68 °C for 15 min after the initial
exposure, reexposed, and the relative decreases in signal were noted.
Results
Preparation ofHybridomas
It proved difficult to obtain successful fusions from 1- and 2-mo-old me"
spleens. The me" splenic cell population contains increased numbers of cells from
the monocytic and granulocytic lineages (2), which may explain the overgrowth
of our first fusion with nonlymphoid cells and the limited number of hybrids we
were able to obtain (the S2 series). A number of approaches were taken to
overcome this problem for the second fusion: a thymocyte feeder layer was used,
fused cells were plated at a fivefold greater dilution than is normally used, and
hybrids were transferred from theplates 5-7 dafter fusion, before overwhelming
overgrowth had occurred. A panning procedure to select for sIg+ cells before
fusion yielded only one hybrid (A-23-10), while all other hybrids of the second
fusion resulted from cells that were not subjected to the panning procedure (the
unselected UN series). The second fusion yielded hybrids in nearly every well,
resembling the yield from fusions of polyclonally activated spleen cells.
More than 350 hybrids obtained were tested for Ig secretion using anti-ic or
anti-X antibodies in a sandwich RIA. Surprisingly, very few (12% of the hybrids)
were secretory (see Table I). This low percentage could be due to the fusion of
nonlymphoid cells or Mott cells (nonsecreting B cells with intracellular Ig
deposits), or it could result from possible B cell defects resulting in a high
incidence of unproductive rearrangements or truncated Ig message. Analysis of
the nonsecreting hybrids will be addressed in future studies.
Number of
obtateed
Number of
Ig secretors
Number of
nonsecg retors
Fraction of
autoantibodies
Number of
multispecific
autoantibodies
1st Fusion 14 6 8 5/6 3/5
(2 mo old)
2nd Fusion 385 41 344 12/27* 8/12
(1 mo old)O
x
E n
U
14.0
12.0
10.0
8,0
6.0
4.0
2.0
0
12.0
10.0
8.0
6.0
4.0
2.0
0
6.0
4.0
2.0
0
0.1
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FIGURE 1 .
￿
Dose-effect relationship of the binding activity of various
concentrations ofmAb(0.1-10 ug/ml) to microtiter plates coated with
either IF (top), heat-aggregated IgG2a (middle), or guinea pig MBP
(bottom). LPS-10 is a monoclonal RF and 15-32 is a monoclonal anti-
MBP (positive controls) .
Frequency ofSelf-reactive Antibodies Produced by me" Hybridomas
In preliminary screening experiments, the binding activity of Ig found in
hybrid cell supernatants was tested against a panel of autoantigens . A high
frequency (17/33) of autoantibodies was observed (see below) . The autoreactive
hybrids were cloned and their antibodies were chromatographically purified on
a rat anti-mouse K chain-Sepharose 4B column (as all positive antibodies had
already been isotyped as bearing K light chain) . The purified mAbs were used in
the subsequent studies on antigen specificity, and two groups of antibodies were
identified based on these studies .
Monospecific Antibodies.
￿
Among this panel of autoreactive antibodies, six were
found to be specific for a single antigen among those tested . Three mAbs bound
to a single soluble antigen in a dose-dependent manner (Fig . 1) . UN-32-15 bound
to IF, UN-17-19 exhibited rheumatoid factor (RF) activity, and S2-9-2 was
specific for MBP . UN-17-19 bound to a determinant common to various classes
of murine IgG but had its highest binding activity to IgG2b (Table II) . The
binding of S2-9-2 and S2-10-9 to MBP obtained from seven different mammalian
species was compared with that of the MBP mAb 15-32 (obtained from an SJL/J
mouse immunized with spinal cord extract) (Table II) . Striking differences were
observed, in that 15-32 exhibited high binding activity to mouse MBP, while
binding activities of both me" antibodies were low . In contrast, theme" antibodies
both showed high binding activity against human, monkey, and rabbit MBP .1142 VIABLE MOTHEATEN ANTIBODIES
TABLE II
Fine Specificity ofRheumatoid Factor- and Myelin Basic Protein-speck Viable Motheaten mAbs
BSA
￿
IgG9 IgGI
￿
IgG26
￿
IgG2a
A. Rheumatoid factor
LPS10-1
￿
1,174 t 92'
￿
6,572 t 91
￿
8,884 t 212
￿
19,512 t 185
￿
14,752 t 1,417
UN-17-19
￿
148 t 1
￿
1,792 t 107
￿
1,104 t 194
￿
4,218 t 1,149
￿
1,825 t 909
BSA Murine Bovine Rat Human Monkey Rabbit
B . Myelin basic protein
15-92
￿
442 t 116
￿
6,299 t 995
￿
1,561 t 59
￿
5,945 t 1,504
￿
29,667 t 885
￿
21,297 t 1,410
￿
29,926 t 1,210
S2-10-9
￿
220 t 1
￿
684 t 191
￿
915 t 80
￿
1,056 t 126
￿
9,826 t 458
￿
5,475 t 946
￿
5,296 t 998
S2-9-2
￿
491 t 7
￿
969 t 85
￿
1,092 t 162
￿
2,881 t 40
￿
7,294 t 519
￿
8,926 t 749
￿
10,988 t 1,897
Guinea
pig
9,929 t 999
2,576 t 412
2,996 t 969
" cpm: Average of triplicates t SD . Microtiter plates coated with 10 #g/ml antigen (IgG or myelin basic protein) in carbonate buffer, pH 9.0,
were incubated with BSA, washed, and then incubated for 9 h at room temperature with 10 vg purified antibody . After washing, the plates
were incubated for 8 h with 1211-rat anti-murine K mAb (50,000 cpm/well).
Some me" mAbs bound to a single cellular antigen: A-23-10 bound to glomer-
ular basal membrane (Fig. 2); UN-5-8 bound to human skin with the same
pattern as HB10, an mAb specific for basal keratinocytes (24) (A-23-10 was used
as a negative control) (Fig. 2); and UN-55-5 bound to nuclear antigen (not
shown).
Multispecific Antibodies.
￿
This second group contained 11 me" mAbs which
exhibited multiple antigen binding patterns (including both soluble and cellular
antigens) (summarized in Table III). S2-6-10 and S2-17-6 both showed binding
activity to MBP and IF (Fig. 3), and to either RBC or Thy, respectively. UN-59-
9 bound to MBP, TG, and RBC, while UN-37-5 bound to TG, AcR, IgG2a and
RBC (data not shown). Three antibodies, UN-40-3, UN-40-6, and UN-40-9,
exhibited similar but not identical patterns of binding to a number of self-
antigens including TG, TR, Sm, MBP, AcR, IF, and IgG2a (Fig. 4). All (11/11)
of the multispecific antibodies exhibited binding to either RBCs or thymocytes
or both. The data presented in Fig. 5 illustrate the three specific patterns of
binding to either or both of these cell types. It should be noted that in all cases
the antibodies bound at most 20-30% of these cell populations, suggesting cell
subset specificities.
To further characterize the unusual antigen binding spectrum of the multispe-
cific antibodies, we carried out competitive inhibition RIA analysis (using the
soluble antigens only). At room temperature, aliquots of multispecific mAbs
were incubated with a given self-antigen, and the antigen binding activity that
remained was revealed in solid-phase RIA. In the case of S2-6-10 and S2-17-6,
the binding to MBP was more strongly inhibited by IF than by MBP, while the
binding to IF was only inhibitable by IF (Fig. 6). In contrast to these two, the
binding to a particular autoantigen of the other five multispecific antibodies
tested was inhibited to various degrees by all of the other autoantigens bound
by a given antibody. A summary of these data is presented in Table IV.
The frequency of autoantibodies was significantly higher among me" hybrido-
mas compared with hybridomas obtained by fusion of nonstimulated C57BL/6J-
nu/nu or C57BL/6J mice. Only 4 of 144 hybridomas obtained from nude and 5
of 36 Iga-producing hybridomas obtained from C57BL/6J exhibited binding to
self-antigens. The data depicted in Table V show that multispecific antibodiesPAINTER ET AL .
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TABLE III
Summary Results: Immunochemical andMolecular Characteristics of Viable Motheaten mAbs
VIABLE MOTHEATEN ANTIBODIES
Thy
MBP, myelin basic protein; IF, intrinsic factor; TG, thyroglobulin; RF, rheumatoid factor; AcR,
acetylcholine receptor; TR, transferrin; IgG, gamma globulin; Br-RBC, bromelain-treated RBC
membrane; GBM, glomerular basal membrane; RBC, red blood cells; Thy, thymocytes; NI, not
identified; ND, not done.
FIGURE 3.
￿
Dose-effect relationship of the bind-
ing activity of various concentrations (0.1-10
,ug/ml) of two mAbs, S2-6-10 and S2-17-6, to mi-
crotiter plates coated with either IF or MBP. 15-
32 is a monoclonal anti-MBP positive control.
Designation Isotype V Vk Antigen specificity
S2-6-10 arc 7183 10 MBP, IF, Thy
S2-9-2 /6K J558 NI MBP
S2-10-9 y3K J558 1 MBP, RBC, Thy
S2-14-2 7,K J606 10 RBC, Thy
S2-17-6 /1K 7183 NI MBP, IF, RBC
A23-10 AK S107 19 GBM
UN-5-8 Arc 5107 NI Skin
UN-17-19 UK X24 4 IgG
UN-32-15 UK J558 10 IF
UN-34-11 /AK ND ND RBC, Thy
UN-37-5 UK J606 4 TG,AcR, IgG, RBC
UN-40-3 AK 7183/X24 1 IF, TG,AcR, IgG, RBC
UN-40-6 UK 7183/X24 1 TG,Sm, TF, MBP, IgG, RBC,
UN-40-9 /6K 7183/X24 1 IF, TG, Br-RBC, RBC, Thy
UN-42-5 AK J606 10 Thy, RBC
UN-55-5 /UK S107 NI Nuclearantigen
UN-59-9 AK J558 19 MBP, TG, RBC
16.0
14.0
0-S2-6-10, MBP
o--S2-17-6, MBP
0-"15-320, MBP
"- S2-6-10,IF
12.0
"-"S2-17-6, IF
10,0PAINTER ET AL .
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FIGURE 4.
￿
Dose-effect relationship of the binding activity
of various concentrations (0.1-10,ug/ml) or mAb UN-40-3
to microtiter plates coated with AcR,TG, IF, or heat-aggre-
gated IgG2a .
were also observed among autoantibodies obtained from unstimulated lympho-
cytes, but the antigen specificities displayed were different from me" autoanti-
bodies .
Northern Analysis ofVH and V K Gene Family Usage
An overrepresentation of 3' VH gene families among autoantibodies has been
reported (25, 26), and a high usage of several VK gene families among murine
and human RFs has been observed (27, 28) . Therefore, we examined the VH
and VK gene family usage in me" monoclonal autoantibodies to determine if any
preferential usage had occurred . Three autoantibodies used VHJ606 ; one used
VH X24; four used Vi, J558 ; three used VH S107 ; two used VH 7183 ; and three
autoantibodies exhibited crosshybridization to VH X24 and VH 7183 (Fig. 7A
andTable III) . It hasbeen previously observed (29) thatundernormal stringency
hybridization conditions, crosshybridization may occur between VH 7183 and
VH X24.
Among the 16 autoantibodies tested, VK4 andV.19 were used twice each, and
V.1 and V.10 were each used four times (Fig . 7B and Table II1) . Since 12 of 16
me" autoantibodies used genes from four VK subgroups (V, 1,VK4, V, 10 or V.19),
the other four must use VK genes of the remaining 18 families . This usage is
substantially different from that observed in 35 hybridomas obtained by fusion
of resting (nonstimulated) C57BL/6J lymphocytes. The data depicted in Table
VI indicate a more random usage of VK gene families among nonstimulated
C57BL/6J-derived hybridomas (selected by Igrc secretion) than among the me"
autoantibodies reported here . Table III summarizes the antigen specificities,
isotypes, and V gene family usage among the panel of 17 me"-derived autoanti-
bodies .
Discussion
The extreme severity of the autoimmune process in me and me" mice (1, 3)
and the fact that most or all of the B cells of these mice are of the Ly-1 B cell1146
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FIGURE 5 .
￿
Three binding patterns of me" mAbs to thymocytes and erythrocytes . RBCs or
thymocytes from 1-2-mo-old C57BL/6J mice were reacted with culture supernatants from
the indicated clones, counterstained with (1 :10) FITC-goat anti-mouse Ig, and the scatter-
gated (90° X forward) populations were examined for fluorescence on a cytofluorograph. In
this experiment, the percentages of cells considered fluorescent (i .e ., within gate 3 indicated
were :
Staining is on a log scale . x-axis, fluorescence ; y-axis, number of cells .
1 st Antibody
Thy
Fluorescent cells
RBC
- 3 5
40-3 4 33
42-5 31 23
6-10 10 4PAINTER ET AL.
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FIGURE 6 .
￿
Percent inhibitionofbinding activity ofmAb
S2-17-6 or S2-6-10 to MBP- or IF-coated microtiter plates
(as indicated at thebottom of the figure) in the presence
of the inhibitor antigen (indicated above each pair of
vertical bars) . Open and dashed bars represent results
obtained using 10 and 30 Pg/ml ofinhibitor, respectively .
15-32 is a monoclonal anti-MBP positive control.
TABLE IV
Binding Specificity to Soluble Autoantigens ofMultiply-reactive Antibodies
Abbreviations as in Table III, and G2a, gamma globulin 2a .
lineage (4), make motheaten mice an interesting and important model for
studying the genetic etiology of autoimmune disease.
The isotype distribution of the antibodies produced by hybridomas from l-
and 2-mo-old me" mice (i.e ., mostly IgM, with one each IgG3, IgA, and IgGl)
was similar to that observed in the serum of me" mice (4). The sole presence of
IgM-secreting hybrids from the fusion of 1-mo-old me" splenocytes correlates
with the in vivo elevation ofserum IgM levels occurring as early as 3 wk of age .
Designa-
tion Binding activity
Inhibition of binding (>50%)
To : By:
S2-6-10 MBP, IF MBP IF
IF IF
S2-17-6 MBP, IF MBP IF
IF IF
UN-59-9 MBP, TG MBP MBP, TG
TG TG
UN-37-5 TG, AcR, G2a TG TG, G2a
AcR TG, G2a, AcR
G2a G2a
UN-40-3 IF, TG, AcR, G2a IF IF, TG
TG TG, G2a
AcR TG, G2a
G2a TG, G2a
UN-40-6 TG, Sm, TR, MBP, G2a, Sm TG TG, MBP, G2a, Sm
Sm Sm, MBP, G2a
TR G2a
MBP MBP, G2a
G2a MBP, TG, G2a, Sm
UN-40-9 IF, TG, G2a, Br-RBC IF IF, TG, G2a, Br-RBC
TG IF, TG, Br-RBC
G2a IF, G2a, Br-RBC
Br-RBC IF, TG, G2a, Br-RBC1148
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TABLE V
Specificity ofAutoantibodies Obtained from C57BL/6fSmn-nu/nu and
C57BL/6fSmn Unstimulated Spleen Lymphocytes
Abbreviations: IF, intrinsic factor ; TG, thyroglobulin ; RF, rheumatoid factor ; CII,
collagen type II ; CIII, collagen type III .
* This specificity was not tested foramong me" antibodies.
FIGURE 7 .
￿
Northern blots of total cytoplasmic RNA probed with indicated V (A) or V, (B)
probes . LPS10-4 is aV 7183 positive control ; 3-23-2 is a VX24' control ; IDA-10 is aJ558'
control ; HOPC8 is an 5107' control ; 1ON109/1 is a V,4' control; NN20/9 is a VR10' control .
Origin of hybri-
domas
Frequency
ofautoanh-
bodies
Designa-
tion Specificity Reference
N100-1 IF, TG, DNA*
C57BL/6fSmn- 4/144 N63-3 TG, IF 33
nu/nu
N65-1 RF
N64-1 TG
C57BL/6fSmn 5/35 B6-105 IF, RF, CII, CIII,* 33a
TG
B6-112 IF, CII, CIII*
B6-21 CII, TG, RB
B6-22 TG, Thy
B6-46 TGPAINTER ET AL .
TABLE VI
Frequency ofVFamilies Used by me' Autoantibodies and by
Antibodies Secreted by Hybridomas Obtained From Fusion of
Nonstimulated C57BL/6jSmn MouseLymphocytes
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Interestingly, no X-bearing autoantibodies were found, even though up to one-
third of the total me"-derived serum IgM expresses the X isotype (4) .
Among our panel of me"-derived antibodies, 33 were tested for antigen
specificity and of these, 17 were self-reactive . Most of the reported in vivo
autoantigen specificities of me" mice (e.g ., antibodies reactive with skin, kidney,
nuclear antigens, thymocytes, or erythrocytes) were represented in this panel.
These specificities may directly contribute to the documented pathophysiology
of me" mice .
Additionally, we identified hybridomas producing antibodies reactive with IF,
TR, MBP, andTG . However, neither demyelinizing encephalitis nor thyroiditis
has been observed in me" mice . The life span of me" mice (average of 9 wk) may
be too short for disease processes due to these autoantibodies to be manifested .
Most (11/17) of the autoantibodies from me" mice exhibited multiple binding
properties . Autoantibodies able to bind to several self-antigens have been ob-
served in humans (30) as well as in mice (31, 32) . In murine systems, this type of
antibody has been found among those produced by hybridomas prepared from
unstimulated lymphocytes of adult C57BL/6J euthymic or athymic (nude) mice
(33), and from adult mice subsequent to polyclonal stimulation (8) .
Competitive inhibition binding assays suggest that some multispecific antibod-
ies are more reactive for one antigen than to another. This was the case for S2-
6-10 and S2-17-6, both ofwhich bound to MBP and IF, and where the inhibition
of binding to both of these antigens was significantly stronger with IF than with
MBP. Five antibodies exhibited a variety of binding activities that were all
inhibitable to various degrees by all of the recognized soluble antigens . It has
been suggested that multispecific autoantibodies may have housekeeping func-
tion (34) and may not be involved in autoimmune pathogenesis . Alternatively,
somatic mutation events occurring in the genes used may confer a stronger
affinity for a given autoantigen and result in pathogenic autoantibodies .
The frequency of multispecific autoantibodies among our panel of me"-derived
antibodies (11/33) was significantly higher than those obtained from the non-
autoimmune strains BALB/c (2/356 [8]), C57BL/6JSmn nude (2/144 [33]), and
V, Family Motheaten C57BL/6J
V,1 4/16 1/35
V,2 0/16 2/35
V,4 2/16 3/35
V.8 0/16 1/35
V,9 0/16 1/35
V,10 4/16 0/35
V,19 2/16 2/35
V,21 0/16 2/35
V,22 0/16 1/35
V,24 0/16 0/35
NI 4/16 25/351150
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C57BL/6JSmn (3/35 [33a; Table IV]). Of 18 autoantigen specificities screened,
11 were represented among 17 me"-derived autoantibodies, indicating that a
broad range of autoantigen specificities exists among me" antibodies. Both the
high frequency of multispecific autoantibodies and the broad range of autoanti-
gens recognized may contribute to the pathogenesis of the several syndromes in
me" autoimmune disease.
The broad range of autoantigen specificities observed among the me"-derived
monoclonals may reflect polyclonal activation of me" B cells that is not driven by
autoantigens. Two findings are important in this regard. First, high levels of a
novel B cell-produced B cell maturation factor (BMF) have been reported in me"
mice (35). Moreover, most of the me" hybridomas reported here secreted detect-
able amounts of this factor (data not shown). Second, all or nearly all me" B cells
appear to be of the Ly-1 B lineage (4). These cells are responsible for most of
the antithymocyte and anti-DNA autoantibody production in NZB mice, as well
as a significant portion of the anti-Br-RBC response (6). Adoptive transfer
experiments indicate that Ly-1 B cells are an independent lineage and possess an
immature phenotype (increased sIgM and decreased sIgD) (reviewed in reference
36). It has been suggested that the predominance of the Ly-1 + phenotype among
me" B cells may reflect an altered regulatory process during immune system
development (4). Whether the elevated level of BMF is causally connected to the
Ly-1 B cell predominance, or whether Ly-1 B cells are polyclonally activated by
BMF, remain unanswered questions. For whatever reason, however, our data
strongly suggest a high frequency of self-reactive B cells (17/33) in the Ly-1 B
cell population in me" mice.
In these me" autoantibodies, we have observed a predominant usage (12/16)
of four VK gene families whose usage was reported to be frequent in murine RFs
(27) and other autoantibodies of various specificities (33a). In particular, the
frequencies of two of these VK families (VK1 and V,10) in me"-derived hybridomas
were significantly higher than those observed in C57BL/6JSmn-derived hybri-
domas, and accounted for 8 of 16 me"-derived but only 1 of 35 C57BL/6JSmn-
derived hybridomas. The me"-derived hybridomas did not, however, show the
biased usage of 3' VH gene families, which was previously observed among
autoantibodies spontaneously produced in animals prone to autoimmune disease
(15, 16). Rather, the utilization of VH families among autoantibodies produced
by me" mice was similar to that observed by antibodies obtained from LPS-
stimulated lymphocytes from normal strains (37).
In summary, the high frequency of autoantibodies possessing multispecific
binding properties, and the utilization of a wide variety of VH but predominantly
four VK gene families, appear to be due to an immunoregulatory defect in me"
mice operating at a more generalized level than the VH and VK loci.
Summary
Several hundred hybridomas were obtained from 1-2-mo-old viable motheaten
(me") mice. Among the Ig-secreting hybridomas tested, >50% (17/33) exhibited
reactivity for autoantigens, supporting the idea that the Ly-1 Bcells that predom-
inate in me" mice contain frequent precursors of autoantibody-forming cells.
Certain of the specificities of these autoantibodies correlated with the docu-PAINTER ET AL .
￿
115 1
mented pathophysiology ofme" mice (antithymocyte, -erythrocyte, -skin, -kidney,
and -IgG) ; others were specific for autoantigens not previously observed in
motheaten mice but thought to be involved in other autoimmune diseases (e.g .,
intrinsic factor, transferrin, myelin basic protein, and thyroglobulin) . About 2 of
3 (11/17) of the self-reactive antibodies exhibited multispecific binding activity
for various autoantigens .
Analysis by Northern blotting of the V gene families used in me" autoantibodies
showed a random usage of VH families and a biased usage of four VK gene
families . Of 16 autoantibodies tested, 12 used a V K gene from theV.1, 4, 10, or
19 families . These patterns ofVKgene usage differ from nonautoimmune control
animals .
Overall, an immunoregulatory defect operating at a more generalized level
than the VH or VK loci, and due to a single gene mutation, appears to be
responsible for the multiple immune abnormalities of me" mice .
We thank Drs . G . A . Carlson and D . C . Roopenian for their critical reading of and
comments on this paper ; Dr . Audrey Manheimer-Lory for critical and helpful discussions
during the course of this study, and Robin Quartin for RIA measurements of the binding
of antibodies to thymocytes.
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